Multimodal Imaging in Vitreo-retinal Surgery and Macular Dystrophies
- Conditions
- Macular HolesMacular DystrophiesEpiretinal MembraneRetinal Detachment
- Interventions
- Diagnostic Test: BiometryDiagnostic Test: Retinography (Color) + Autofluorescence (AF)Diagnostic Test: OCT B-scan and OCT angiography (OCTA)Diagnostic Test: MicroperimetryDiagnostic Test: Electrophysiological exams
- Registration Number
- NCT05747144
- Brief Summary
The aim of the study is to identify morphological and functional biomarkers of post-operative recovery after vitreoretinal surgery, using decisional support systems (DSS), based on multimodal big-data analysis by means of machine learning techniques in daily clinical practice
- Detailed Description
The aim of the study is to identify morphological and functional biomarkers of post-operative recovery after vitreoretinal surgery. Identifying the biomarkers and assessing the predictivity of recovery will make it possible to highlight the categories of patients who can benefit most from surgical treatment, and to target the patient more precisely for personalised medicine and surgery. The introduction of new decisional support systems (DSS), based on multimodal big-data analysis through machine learning techniques in daily clinical practice, is providing new useful information in patient assessment for personalised surgery.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
-
All patients to undergo vitreo-retinal surgery for:
- Macular hole
- Epiretinal membranes
- Retinal detachment
- Macular dystrophies (retinal pre-prosthesis)
- Patients under 18 years of age will be excluded; patients in whom morphological examinations cannot be performed due to poor cooperation or opacity of the dioptric media (e.g. corneal pathology). Quality of morphological images inadequate for post acquisition processing (<6/10).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Macular dystrophies Biometry Patients affected by macular dystrophies. Macular dystrophies Microperimetry Patients affected by macular dystrophies. Epiretinal membranes Microperimetry Patients affected by epiretinal membrane. Macular dystrophies OCT B-scan and OCT angiography (OCTA) Patients affected by macular dystrophies. Macular hole Biometry Patients affected by macular hole. Retinal detachment OCT B-scan and OCT angiography (OCTA) Patients affected by retinal detachment. Retinal detachment Microperimetry Patients affected by retinal detachment. Retinal detachment Electrophysiological exams Patients affected by retinal detachment. Macular dystrophies Electrophysiological exams Patients affected by macular dystrophies. Macular hole OCT B-scan and OCT angiography (OCTA) Patients affected by macular hole. Macular hole Electrophysiological exams Patients affected by macular hole. Epiretinal membranes Biometry Patients affected by epiretinal membrane. Epiretinal membranes Retinography (Color) + Autofluorescence (AF) Patients affected by epiretinal membrane. Macular hole Retinography (Color) + Autofluorescence (AF) Patients affected by macular hole. Macular hole Microperimetry Patients affected by macular hole. Epiretinal membranes OCT B-scan and OCT angiography (OCTA) Patients affected by epiretinal membrane. Epiretinal membranes Electrophysiological exams Patients affected by epiretinal membrane. Retinal detachment Biometry Patients affected by retinal detachment. Retinal detachment Retinography (Color) + Autofluorescence (AF) Patients affected by retinal detachment. Macular dystrophies Retinography (Color) + Autofluorescence (AF) Patients affected by macular dystrophies.
- Primary Outcome Measures
Name Time Method Predictivity of morphological-functional radiomic data 3 years Rate of predictivity of morphological-functional radiomic data to establish the grade of recovery in the post-operative period by means of an artificial intelligence (AI) machine learning model.
- Secondary Outcome Measures
Name Time Method Correlating with the age of patients 3 years Identify predictive differences according to diagnosis and correlate them with the age of patients
Correlate with age of onset of disease 3 years Identify predictive differences according to diagnosis and correlate them with the age of onset of disease
Identify predictive differences according to diagnosis 3 years Subdivision into subgroups in order to identify predictive differences according to diagnosis
Trial Locations
- Locations (1)
Prof. Stanislao Rizzo
🇮🇹Rome, Italy